foxo4-dri senolytic peptide human trials trial Development of a novel senolytic by precise disruption of FOXO4 Peptide inhibitors targeting FOXO4-p53 interactions – Development of a novel senolytic
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

























